Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3093 |
|
Actual shortage: | 246 (8%) | |
Anticipated shortage: | 15 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2823 (91%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-WARFARIN | 4MG | TABLET | Resolved | 2017-03-12 | 2017-06-08 | 695 |
APO-WARFARIN | 4MG | TABLET | Resolved | 2018-05-23 | 2018-07-03 | 50162 |
APO-WARFARIN | 2.5MG | TABLET | Resolved | 2020-01-08 | 2020-06-08 | 102666 |
APO-WARFARIN | 2.5MG | TABLET | Resolved | 2020-01-08 | 2020-06-08 | 102671 |
APO-WARFARIN | 5MG | TABLET | Resolved | 2020-04-13 | 2020-05-28 | 111966 |
APO-WARFARIN | 1MG | TABLET | Resolved | 2020-04-15 | 2020-05-11 | 112208 |
APO-WARFARIN | 10MG | TABLET | Resolved | 2020-05-13 | 2020-06-22 | 114970 |
APO-WARFARIN | 2MG | TABLET | Resolved | 2020-05-13 | 2020-07-28 | 114975 |
APO-WARFARIN | 5MG | TABLET | Resolved | 2020-07-08 | 2020-09-21 | 119773 |
APO-WARFARIN | 5MG | TABLET | Resolved | 2020-07-29 | 2020-09-21 | 121343 |
APO-WARFARIN | 5MG | TABLET | Resolved | 2020-10-21 | 2020-12-28 | 126780 |
APO-WARFARIN | 1MG | TABLET | Resolved | 2023-11-17 | 2023-12-22 | 210698 |
APO-WARFARIN | 1MG | TABLET | Resolved | 2024-04-05 | 2024-05-15 | 224589 |
APO-WARFARIN | 1MG | TABLET | Resolved | 2024-04-19 | 2024-05-15 | 225782 |
APO-WARFARIN | 2.5MG | TABLET | Actual shortage | 2024-05-31 | 2024-05-31 | 229419 |
APO-WARFARIN | 1MG | TABLET | Actual shortage | 2024-06-13 | 2024-06-13 | 230483 |
APO-ZOLMITRIPTAN | 2.5MG | TABLET | Resolved | 2017-10-12 | 2018-02-26 | 25646 |
APO-ZOLMITRIPTAN RAPID | 2.5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-10-12 | 2018-09-12 | 25649 |
APO-ZOLPIDEM ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-03-10 | 2017-04-10 | 245 |
APO-ZOLPIDEM ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2017-03-10 | 2017-04-17 | 249 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-HYDROMORPHONE CR | 4.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110974 |
APO-HYDROMORPHONE CR | 9MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110977 |
APO-HYDROXYQUINE | 200MG | TABLET | Discontinued | 2018-09-07 | 2018-10-05 | 60524 |
APO-IMIQUIMOD | Discontinued | 2019-11-26 | 2019-11-26 | 99672 | ||
APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60536 |
APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60539 |
APO-IRBESARTAN | 75MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71231 |
APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71234 |
APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71237 |
APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-02-23 | 40757 |
APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40760 |
APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40766 |
APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40769 |
APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
APO-LAMIVUDINE | 150MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60557 |
APO-LAMIVUDINE | 300MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60560 |
APO-LAMIVUDINE HBV | 100MG | TABLET | Discontinued | 2018-09-07 | 2019-12-21 | 60563 |
APO-LATANOPROST-TIMOP | Discontinued | 2018-09-07 | 2018-09-15 | 60572 | ||
APO-LEVOCARB - TAB 25MG/250MG | 25MG 250MG | TABLET | Discontinued | 2018-09-07 | 2019-02-07 | 60576 |